Breaking News Instant updates and real-time market news.

BA

Boeing

$133.94

0.5566 (0.42%)

, AMGN

Amgen

$164.29

0.41 (0.25%)

13:02
10/14/16
10/14
13:02
10/14/16
13:02

Boeing names Amgen CEO Robert Bradway to board

The Boeing (BA) board of directors has elected Robert A. Bradway as a new member. Bradway is chairman and CEO of Amgen (AMGN).

BA

Boeing

$133.94

0.5566 (0.42%)

AMGN

Amgen

$164.29

0.41 (0.25%)

  • 26

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Jul

BA Boeing
$133.94

0.5566 (0.42%)

06/23/16
06/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), eBay (EBAY), and Groupon (GRPN) initiated with a Buy at Maxim. 2. Boeing (BA) initiated with an Overweight at Morgan Stanley. 3. Wal-Mart (WMT) coverage assumed with a Buy at Nomura. 4. Textron (TXT) initiated with an Underweight at Morgan Stanley. 5. ANI Pharmaceuticals (ANIP) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/16
BERN
07/28/16
NO CHANGE
BERN
Boeing reported beat and raise results, says Bernstein
Bernstein analyst Douglas Harned says that Boeing reported higher than expected Q1 EPS and effectively raised its EPS guidance by $1..18 per share. Harned says that the company's 787 unit margins appear to be running ahead of expectations. He expects the company to generate strong cash flow growth going forward. Harned keeps a $176 price target and Outperform rating on the stock.
10/05/16
BARD
10/05/16
INITIATION
BARD
Outperform
Boeing initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Boeing with an Outperform and a $161 price target.
10/06/16
10/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with an Outperform at Baird. 2. AMC Networks (AMCX) initiated with an Outperform at FBN Securities. 3. CVS Health (CVS) initiated with a Buy at UBS. 4. L-3 Communications (LLL) initiated with an Outperform at Baird. 5. Raytheon (RTN) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AMGN Amgen
$164.29

0.41 (0.25%)

09/01/16
09/01/16
NO CHANGE

Amgen's sBLA for Blincyto approved by FDA
Amgen's supplemental Biologics License Application for Blincyto has been approved by the FDA to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. This indication is approved under accelerated approval, and continued approval may be contingent upon verification of clinical benefit in subsequent trials. The approval is based on results from the Phase 1/2 '205, an open-label, multicenter, single-arm trial, which evaluated the efficacy and safety of BLINCYTO in pediatric patients with relapsed or refractory B-cell precursor ALL. Blincyto was granted breakthrough therapy, priority review and orphan drug designations by FDA, and is now approved in the U.S. for the treatment of Ph- relapsed or refractory B-cell precursor ALL. In November 2015, BLINCYTO was granted conditional marketing authorization in the European Union for the treatment of adults with Ph- relapsed or refractory B-cell precursor ALL.
09/27/16
GSCO
09/27/16
NO CHANGE
Target $206
GSCO
Conviction Buy
Goldman surprised by Amgen's Kyprolis outcome in first-line multiple myeloma
Last night, Amgen announced Phase 3 Kypolis CLARION study did not meet the primary endpoint in first-line multiple myeloma. Goldman analyst Terence Flynn was surprised by this outcome given the prior positive superiority data for Kyprolis versus Velcade in the Phase III ENDEAVOR trial. Flynn sees risk to his Kyprolis $1B sales estimate in a first-line setting, but awaits for additional details from the call and further information regarding another ongoing Phase III trial. He expects Amgen shares to be weak on the news but said the company has additional drivers beyond Kyprolis including Repatha for high cholesterol and Erenumab for migraine with additional data expected in 2H 2016 and Q1 2017. Flynn remains Conviction Buy rated on Amgen and maintains his $206 price target.
09/27/16
PIPR
09/27/16
NO CHANGE
PIPR
Overweight
Amgen's Kyprolis in good shape despite trial miss, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Amgen's Kyprolis is still likely to be viewed as a "potent backbone, with the right drugs" after a Phase 3 study in front-line myeloma failed to reach its primary endpoint. The analyst believes the impact of the failed trial on Kyprolis use will be limited and he reiterates an Overweight rating on Amgen.
09/29/16
PIPR
09/29/16
NO CHANGE
Target $10
PIPR
Overweight
Arrowhead price target raised to $10 from $8 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Arrowhead Pharmaceuticals (ARWR) to $10 after the company licensed two preclinical cardiovascular RNAi drugs with Amgen (AMGN). Amgen is the "ideal partner" and Arrowhead's balance sheet is now "meaningfully" strengthened, Tenthoff tells investors in a research note. He reiterates an Overweight rating on Arrowhead.

TODAY'S FREE FLY STORIES

VMI

Valmont

$154.30

4.45 (2.97%)

08:59
12/08/16
12/08
08:59
12/08/16
08:59
Recommendations
Valmont analyst commentary  »

Valmont facing multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

REXR

Rexford Industrial

$22.41

0.41 (1.86%)

08:57
12/08/16
12/08
08:57
12/08/16
08:57
Hot Stocks
Rexford Industrial acquires industrial property for $24.4M, sells two for $19M »

Rexford Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$59.84

2.6 (4.54%)

, HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

08:56
12/08/16
12/08
08:56
12/08/16
08:56
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS:…

LULU

lululemon

$59.84

2.6 (4.54%)

HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

AMD

AMD

$9.56

0.11 (1.16%)

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

CTRV

ContraVir Pharmaceuticals

$1.99

-0.01 (-0.50%)

AVXL

Anavex

$3.73

-0.1 (-2.61%)

HRB

H&R Block

$23.34

0.65 (2.86%)

VYGR

Voyager Therapeutics

$13.73

-0.27 (-1.93%)

CMTL

Comtech

$12.75

0.77 (6.43%)

VRNT

Verint

$38.30

0.1 (0.26%)

VNCE

Vince Holding

$4.55

0.35 (8.33%)

CASY

Casey's General Stores

$124.22

1.14 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 14

    Dec

  • 09

    Jan

F

Ford

$13.06

0.5 (3.98%)

, BAC

Bank of America

$22.57

0.41 (1.85%)

08:55
12/08/16
12/08
08:55
12/08/16
08:55
Options
Notable open interest changes for December 8th »

Wednesday's total…

F

Ford

$13.06

0.5 (3.98%)

BAC

Bank of America

$22.57

0.41 (1.85%)

AAPL

Apple

$111.03

1.08 (0.98%)

WFC

Wells Fargo

$57.28

1.73 (3.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 05

    Jan

  • 10

    Jan

  • 13

    Jan

  • 13

    Mar

08:55
12/08/16
12/08
08:55
12/08/16
08:55
General news
FX Action: The dollar »

FX Action: The dollar…

BHI

Baker Hughes

$66.14

-0.75 (-1.12%)

08:55
12/08/16
12/08
08:55
12/08/16
08:55
Conference/Events
Baker Hughes to hold an investor meeting »

Investor Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CIEN

Ciena

$21.60

0.6 (2.86%)

08:54
12/08/16
12/08
08:54
12/08/16
08:54
Hot Stocks
Ciena sees Q1 adjusted gross margin in mid-40's percentage range »

Sees Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CIEN

Ciena

$21.60

0.6 (2.86%)

08:51
12/08/16
12/08
08:51
12/08/16
08:51
Hot Stocks
Ciena sees FY17 revenue growth faster than the market »

FY17 consensus $2.8B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AAPL

Apple

$111.03

1.08 (0.98%)

08:50
12/08/16
12/08
08:50
12/08/16
08:50
Periodicals
Apple, Goldwind partner to supply clean energy in China, SCMP reports »

Wind power turbine maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

08:50
12/08/16
12/08
08:50
12/08/16
08:50
General news
The 10k initial claims drop to 258k »

The 10k initial claims…

DRAM

Dataram

$1.27

0.07 (5.83%)

08:48
12/08/16
12/08
08:48
12/08/16
08:48
Hot Stocks
Dataram acquisition targt U.S. Gold Corp. expands claims in Nevada »

Dataram's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCAP

Jernigan Capital

$20.21

-0.05 (-0.25%)

08:48
12/08/16
12/08
08:48
12/08/16
08:48
Syndicate
Jernigan Capital 2.65M share Spot Secondary priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

$DJT

DJ Transportation Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$2.20

-0.1 (-4.35%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Syndicate
Seanergy Marine raises $15M in common stock and warrant offering »

Seanergy Marine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDUS

Radius Health

$53.50

-1.51 (-2.75%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Hot Stocks
Radius Health presents RAD1901 Phase 1 data at SABCS »

Radius Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DJX

Dow Jones Industrial Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$168.84

4.1 (2.49%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$48.18

0.9 (1.90%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$75.95

0.6 (0.80%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$84.12

1.6 (1.94%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$111.36

-15.01 (-11.88%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Recommendations
Universal Health analyst commentary  »

Universal Health selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

XLB

S&P Select Materials SPDR

$51.15

0.72 (1.43%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$47.38

0.61 (1.30%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$51.51

0.73 (1.44%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.